|
Course Information
|
Back to Catalog
|
This lesson is supported by:
|
Program Description
This CE monograph will provide
critical information to assist community pharmacists in understanding
e-prescribing processes and standards, as well as better prepare
community pharmacists to integrate e-prescribing into their workflow.
Faculty
Ken Whittemore, Jr., RPh, MBA
Ken
is Vice President of Professional and Regulatory Affairs for
SureScripts. SureScripts was founded by the National Community
Pharmacists Association and the National Association of Chain Drug
Stores to encourage and promote true electronic prescribing
connectivity between physicians and pharmacists.
Prior to
joining SureScripts, Ken was President and CEO of CARE Pharmacies,
Inc., an independent community pharmacy franchise in the Washington, DC
area. While with CARE, he was responsible for supervising the
transformation of the organization from that of a group purchasing
cooperative to that of a full-service franchise.
During the
decade prior to his CARE tenure, Ken was Vice President for Management,
Professional, and State affairs for the National Community Pharmacists
Association. In this role, he was responsible for monitoring and
formulating strategies for dealing with a wide variety of managed care,
regulatory, and operational issues that confronted NCPA's independent
pharmacy members. He also acted as NCPA's liaison to all state,
regional, and national pharmacy groups.
From 1980 through 1992,
Ken was a principal in a successful independent pharmacy in Western
Maryland. He is a 1976 graduate of the University of Maryland
School of Pharmacy, and is licensed to practice pharmacy in both
Maryland and Pennsylvania. He also has practiced in hospital
pharmacy settings, and holds an MBA degree that was awarded to him by
Mount Saint Mary's College in 1990.
Faculty Disclosure
The
NACDS Foundation has a conflict of interest policy that requires course
faculty to disclose any real or apparent commercial financial
affiliations related to the content of their
presentations/materials. Ken Whittemore, Jr., RPh, MBA, has
declared a financial affiliation with SureScripts.
Disclaimer
The
author, sponsor, and publisher of this continuing education program
have made all reasonable efforts to ensure that information contained
herein is accurate in accordance with the latest available knowledge at
the time of accreditation of this continuing education program.
Learning Objectives
At the conclusion of this program, participants will be better able to:
- Define what is meant by true electronic prescribing connectivity.
- List three potential benefits of electronic prescribing connectivity to patients, pharmacists and physicians.
- Identify three obstacles that have prevented the widespread
adoption of electronic prescribing to date, and describe the ways these
obstacles are now being overcome.
- Discuss the impact that the Medicare Modernization Act of 2003 and
other national initiatives will have on the adoption of electronic
prescribing connectivity.
- Explain how the electronic prescribing infrastructure will likely
be used to provide enhanced patient care services in the future.
Target Audience
This program is appropriate for pharmacists in any practice setting.
|
|
|
|
|
Technologies Used
|
|
|
 Monograph
|
|
|
|
Price: FREE!
|
|
ACPE Accreditation
|
|
The National Association of Chain Drug Stores (NACDS) Foundation is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
This home study web activity has been assigned a maximum of 2 credit hours (0.2 CEU) and the ACPE UPN: 206-000-05-508-H04.
This accreditation expires on 09/28/2008.
|
| |
To receive educational credit, participants must complete an online evaluation form and pass the online assessment with a score of 70% or better. If you do not receive a minimum score of 70% or better, you are permitted 1 retake(s). After passing the assessment, you can view, print and track your statements of credit online. There is no fee to participate in this activity.
|
|
|
The material presented here does not reflect the views of Pharmacy Choice, Inc., RxSchool, or the companies providing educational content. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.
|
This lesson is supported by:
|
|
|
